Detection of auto‐abs against type I IFNs
particle‐based, MERS
Plasma samples from patients with MERS were tested at King Abdullah International Research Center laboratory, Riyadh, Saudi Arabia, for auto‐Abs against IFN‐α2, β, and IFN‐ω using a multiplex particle‐based assay that uses magnetic beads with differential fluorescence that covalently coupled to recombinant human proteins (2.5 μg/reaction) as provided by the National Institutes of Health (NIH), Bethesda, Maryland, United States.